726 related articles for article (PubMed ID: 32442971)
1. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage.
Aldrich EF; Higashida R; Hmissi A; Le EJ; Macdonald RL; Marr A; Mayer SA; Roux S; Bruder N
J Neurosurg; 2020 May; 134(5):1553-1561. PubMed ID: 32442971
[TBL] [Abstract][Full Text] [Related]
2. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
[TBL] [Abstract][Full Text] [Related]
3. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
[TBL] [Abstract][Full Text] [Related]
4. Operative complications and differences in outcome after clipping and coiling of ruptured intracranial aneurysms.
Ayling OG; Ibrahim GM; Drake B; Torner JC; Macdonald RL
J Neurosurg; 2015 Sep; 123(3):621-8. PubMed ID: 26047409
[TBL] [Abstract][Full Text] [Related]
5. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Frey A; Marr A; Roux S; Kassell NF
Neurocrit Care; 2010 Dec; 13(3):416-24. PubMed ID: 20838933
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Acta Neurochir Suppl; 2013; 115():27-31. PubMed ID: 22890639
[TBL] [Abstract][Full Text] [Related]
7. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging characteristics of ruptured aneurysm as predictors of outcome after aneurysmal subarachnoid hemorrhage: pooled analyses of the SAHIT cohort.
Jaja BN; Lingsma H; Steyerberg EW; Schweizer TA; Thorpe KE; Macdonald RL;
J Neurosurg; 2016 Jun; 124(6):1703-11. PubMed ID: 26495952
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
[TBL] [Abstract][Full Text] [Related]
10. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
[TBL] [Abstract][Full Text] [Related]
11. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage.
Ibrahim GM; Vachhrajani S; Ilodigwe D; Kassell NF; Mayer SA; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL
Neurosurgery; 2012 Jan; 70(1):102-9; discussion 109. PubMed ID: 21788917
[TBL] [Abstract][Full Text] [Related]
12. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
13. Isolated abducens nerve palsy associated with subarachnoid hemorrhage: a localizing sign of ruptured posterior inferior cerebellar artery aneurysms.
Burkhardt JK; Winkler EA; Lasker GF; Yue JK; Lawton MT
J Neurosurg; 2018 Jun; 128(6):1830-1838. PubMed ID: 28862551
[TBL] [Abstract][Full Text] [Related]
14. The impact of temporary clipping during aneurysm surgery on the incidence of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
J Neurosurg; 2018 Jul; 129(1):84-90. PubMed ID: 28946178
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
[TBL] [Abstract][Full Text] [Related]
16. Cerebral vasospasm patterns following aneurysmal subarachnoid hemorrhage: an angiographic study comparing coils with clips.
Jones J; Sayre J; Chang R; Tian J; Szeder V; Gonzalez N; Jahan R; Vinuela F; Duckwiler G; Tateshima S
J Neurointerv Surg; 2015 Nov; 7(11):803-7. PubMed ID: 25230840
[TBL] [Abstract][Full Text] [Related]
17. Intrasylvian hematoma caused by ruptured middle cerebral artery aneurysms predicts recovery from poor-grade subarachnoid hemorrhage.
Fukuda H; Hayashi K; Moriya T; Nakashita S; Lo BW; Yamagata S
J Neurosurg; 2015 Sep; 123(3):686-92. PubMed ID: 26052880
[TBL] [Abstract][Full Text] [Related]
18. Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage.
Lindgren A; Vergouwen MD; van der Schaaf I; Algra A; Wermer M; Clarke MJ; Rinkel GJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD003085. PubMed ID: 30110521
[TBL] [Abstract][Full Text] [Related]
19. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Lancet Neurol; 2011 Jul; 10(7):618-25. PubMed ID: 21640651
[TBL] [Abstract][Full Text] [Related]
20. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
